510(k) K192046
K192046 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON XL Zika Capture IgM II and LIAISON XL Zika Capture IgM II Control Set". The FDA issued a decision of Substantially Equivalent on October 28, 2019. The device falls under product code QFO (Zika Virus Serological Reagents), a Class II device regulated under 21 CFR 866.3935. DiaSorin, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 28, 2019
- Date Received
- July 31, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Zika Virus Serological Reagents
- Device Class
- Class II
- Regulation Number
- 866.3935
- Review Panel
- MI
- Submission Type
Zika virus serological reagents are devices that consist of antigens and antisera for the diagnosis of Zika virus infection in human clinical specimens from individuals that have signs and symptoms consistent with Zika virus infection and/or epidemiological risk factors. The device aids in the presumptive clinical diagnosis of Zika virus infection in conjunction with other clinical and laboratory findings.